Your browser is no longer supported. Please, upgrade your browser.
Settings
MRNA [NASD]
Moderna, Inc.
IndexS&P 500 P/E40.76 EPS (ttm)8.01 Insider Own1.90% Shs Outstand402.00M Perf Week0.72%
Market Cap134.93B Forward P/E12.40 EPS next Y26.34 Insider Trans-15.25% Shs Float364.68M Perf Month-28.17%
Income3.49B PEG2.43 EPS next Q9.09 Inst Own58.10% Short Float3.93% Perf Quarter-2.78%
Sales7.02B P/S19.22 EPS this Y-26.10% Inst Trans0.09% Short Ratio0.86 Perf Half Y83.85%
Book/sh16.68 P/B19.58 EPS next Y-9.53% ROA34.20% Target Price306.31 Perf Year360.95%
Cash/sh19.34 P/C16.89 EPS next 5Y16.80% ROE88.10% 52W Range65.49 - 497.49 Perf YTD212.57%
Dividend- P/FCF14.85 EPS past 5Y- ROI-28.40% 52W High-34.36% Beta-
Dividend %- Quick Ratio1.20 Sales past 5Y- Gross Margin86.50% 52W Low398.61% ATR20.11
Employees1300 Current Ratio1.20 Sales Q/Q6398.50% Oper. Margin54.40% RSI (14)41.27 Volatility4.36% 5.85%
OptionableYes Debt/Eq0.07 EPS Q/Q- Profit Margin49.80% Rel Volume0.46 Prev Close339.57
ShortableYes LT Debt/Eq0.05 EarningsNov 04 BMO Payout0.00% Avg Volume16.69M Price326.54
Recom2.70 SMA20-4.49% SMA50-14.79% SMA20035.45% Volume7,736,069 Change-3.84%
Oct-22-21Initiated Deutsche Bank Sell $250
Oct-15-21Upgrade Piper Sandler Neutral → Overweight $445
Aug-06-21Downgrade Piper Sandler Overweight → Neutral $246 → $445
Aug-06-21Downgrade Oppenheimer Outperform → Perform
Jul-15-21Reiterated Jefferies Hold $170 → $250
Feb-01-21Downgrade BofA Securities Neutral → Underperform
Dec-16-20Downgrade Morgan Stanley Overweight → Equal-Weight $150
Dec-16-20Downgrade Jefferies Buy → Hold $90 → $150
Dec-09-20Downgrade Needham Buy → Hold
Nov-23-20Initiated Wells Fargo Equal Weight $92
Nov-17-20Downgrade BMO Capital Markets Outperform → Market Perform $109
Sep-08-20Downgrade SVB Leerink Mkt Perform → Underperform $58 → $41
Jul-23-20Initiated SVB Leerink Mkt Perform
Jul-20-20Downgrade JP Morgan Overweight → Neutral $89
Jul-13-20Initiated Jefferies Buy $90
Jun-30-20Initiated Argus Buy $80
Jun-08-20Initiated Barclays Overweight $68
Apr-30-20Initiated BMO Capital Markets Outperform $83
Mar-05-20Downgrade BofA/Merrill Buy → Neutral $32
Dec-03-19Resumed BofA/Merrill Buy
Oct-24-21 06:58AM  
06:00AM  
Oct-23-21 07:00AM  
12:00AM  
Oct-22-21 06:48PM  
05:01PM  
04:15PM  
03:01PM  
02:22PM  
12:07PM  
11:32AM  
10:15AM  
10:01AM  
09:46AM  
09:46AM  
09:05AM  
08:42AM  
08:30AM  
08:17AM  
07:36AM  
05:37AM  
Oct-21-21 09:05PM  
07:48PM  
06:12PM  
05:49PM  
05:45PM  
04:08PM  
04:03PM  
04:00PM  
03:36PM  
01:31PM  
12:57PM  
12:44PM  
11:17AM  
11:15AM  
10:35AM  
10:00AM  
09:45AM  
09:40AM  
08:45AM  
08:11AM  
07:56AM  
07:42AM  
06:05AM  
Oct-20-21 07:32PM  
07:28PM  
06:31PM  
05:40PM  
05:37PM  
05:19PM  
05:13PM  
05:08PM  
05:08PM  
02:39PM  
01:14PM  
12:09PM  
06:30AM  
06:02AM  
Oct-19-21 03:35PM  
11:30AM  
11:15AM  
08:23AM  
06:47AM  
06:34AM  
05:52AM  
02:05AM  
Oct-18-21 01:11PM  
12:27PM  
11:25AM  
11:19AM  
11:03AM  
10:29AM  
08:34AM  
Oct-17-21 07:45AM  
07:00AM  
Oct-16-21 06:33AM  
Oct-15-21 08:54PM  
06:56PM  
06:03PM  
05:47PM  
04:53PM  
04:45PM  
04:28PM  
04:24PM  
04:24PM  
04:10PM  
03:51PM  
03:49PM  
02:51PM  
02:42PM  
02:14PM  
02:12PM  
02:10PM  
01:54PM  
01:50PM  
01:42PM  
01:39PM  
12:04PM  
11:51AM  
11:02AM  
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of COVID-19 vaccine; and Catalent Inc., Laboratorios Farmaceuticos Rovi, S.A., Recipharm, and Lonza Group for fill-finish manufacturing of its COVID-19 vaccine candidate, as well as Aldevron, LLC for supporting COVID-19 vaccine and additional programs in company's clinical development pipeline. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bancel StephaneChief Executive OfficerOct 21Sale337.0010,0003,370,0007,184,880Oct 22 05:23 PM
Andres JuanSee remarksOct 20Option Exercise12.215,00061,0505,000Oct 22 05:39 PM
Bancel StephaneChief Executive OfficerOct 20Sale333.909,0003,005,1006,035,868Oct 22 05:23 PM
Andres JuanSee remarksOct 20Sale333.905,0001,669,5000Oct 22 05:39 PM
Andres JuanSee remarksOct 18Option Exercise12.215,00061,0505,000Oct 19 04:11 PM
Andres JuanSee remarksOct 18Sale322.265,0001,611,3000Oct 19 04:11 PM
Andres JuanSee remarksOct 15Option Exercise12.215,00061,0505,000Oct 19 04:11 PM
Andres JuanSee remarksOct 15Sale341.255,0001,706,2500Oct 19 04:11 PM
Bancel StephaneChief Executive OfficerOct 14Sale329.0010,0003,290,0007,194,880Oct 15 04:05 PM
Hoge StephenPresidentOct 13Option Exercise4.2915,00064,4001,624,597Oct 14 04:10 PM
Andres JuanSee remarksOct 13Option Exercise12.215,00061,0505,000Oct 14 04:21 PM
SAGAN PAULDirectorOct 13Sale314.902,250708,52514,951Oct 15 04:03 PM
Bancel StephaneChief Executive OfficerOct 13Sale314.909,0002,834,1006,048,868Oct 15 04:05 PM
Hoge StephenPresidentOct 13Sale314.9015,0004,723,5001,609,597Oct 14 04:10 PM
Andres JuanSee remarksOct 13Sale314.905,0001,574,5000Oct 14 04:21 PM
Hoge StephenPresidentOct 12Option Exercise10.905,00054,5001,614,597Oct 14 04:10 PM
Hoge StephenPresidentOct 12Sale313.225,0001,566,1001,609,597Oct 14 04:10 PM
Andres JuanSee remarksOct 11Option Exercise12.2115,000183,15015,000Oct 12 04:16 PM
Andres JuanSee remarksOct 11Sale300.0015,0004,500,0000Oct 12 04:16 PM
Andres JuanSee remarksOct 08Option Exercise12.215,00061,0505,000Oct 12 04:16 PM
Andres JuanSee remarksOct 08Sale310.445,0001,552,2000Oct 12 04:16 PM
Bancel StephaneChief Executive OfficerOct 07Sale295.0010,0002,950,0007,204,880Oct 08 04:14 PM
Andres JuanSee remarksOct 06Option Exercise12.215,00061,0505,000Oct 08 04:18 PM
Bancel StephaneChief Executive OfficerOct 06Sale318.239,0002,864,0706,061,868Oct 08 04:14 PM
Andres JuanSee remarksOct 06Sale318.235,0001,591,1500Oct 08 04:18 PM
Hoge StephenPresidentOct 04Option Exercise0.9920,00019,8001,629,597Oct 06 04:09 PM
Andres JuanSee remarksOct 04Option Exercise12.215,00061,0505,000Oct 05 04:12 PM
Hoge StephenPresidentOct 04Sale307.5420,0006,150,8001,609,597Oct 06 04:09 PM
Andres JuanSee remarksOct 04Sale307.545,0001,537,7000Oct 05 04:12 PM
Andres JuanSee remarksOct 01Option Exercise12.215,00061,0505,000Oct 05 04:12 PM
Andres JuanSee remarksOct 01Sale359.005,0001,795,0000Oct 05 04:12 PM
Bancel StephaneChief Executive OfficerSep 30Sale381.8210,0003,818,2007,214,880Oct 01 08:50 AM
Andres JuanSee remarksSep 29Option Exercise12.215,00061,0505,000Oct 01 08:53 AM
Bancel StephaneChief Executive OfficerSep 29Sale393.449,0003,540,9606,074,868Oct 01 08:50 AM
Andres JuanSee remarksSep 29Sale393.445,0001,967,2000Oct 01 08:53 AM
Andres JuanSee remarksSep 27Option Exercise12.2115,000183,15015,000Sep 28 04:22 PM
Andres JuanSee remarksSep 27Sale429.3815,0006,440,7000Sep 28 04:22 PM
Hoge StephenPresidentSep 24Option Exercise10.905,00054,5001,614,597Sep 27 04:11 PM
Andres JuanSee remarksSep 24Option Exercise12.215,00061,0505,000Sep 28 04:22 PM
Hoge StephenPresidentSep 24Sale448.045,0002,240,2001,609,597Sep 27 04:11 PM
Andres JuanSee remarksSep 24Sale448.045,0002,240,2000Sep 28 04:22 PM
Hoge StephenPresidentSep 23Option Exercise4.2915,00064,4001,624,597Sep 27 04:11 PM
Bancel StephaneChief Executive OfficerSep 23Sale439.4510,0004,394,5007,224,880Sep 24 04:17 PM
Hoge StephenPresidentSep 23Sale448.6015,0006,728,9391,609,597Sep 27 04:11 PM
Andres JuanSee remarksSep 22Option Exercise12.215,00061,0505,000Sep 24 04:09 PM
Andres JuanSee remarksSep 22Sale433.005,0002,165,0000Sep 24 04:09 PM
Bancel StephaneChief Executive OfficerSep 22Sale433.009,0003,897,0006,087,868Sep 24 04:17 PM
Andres JuanSee remarksSep 20Option Exercise12.215,00061,0505,000Sep 21 04:17 PM
Andres JuanSee remarksSep 20Sale417.625,0002,088,1000Sep 21 04:17 PM
Andres JuanSee remarksSep 17Option Exercise12.215,00061,0505,000Sep 21 04:17 PM
Andres JuanSee remarksSep 17Sale438.245,0002,191,2000Sep 21 04:17 PM
Bancel StephaneChief Executive OfficerSep 16Sale431.3010,0004,313,0007,234,880Sep 17 05:23 PM
Andres JuanSee remarksSep 15Option Exercise12.215,00061,0505,000Sep 17 05:26 PM
Bancel StephaneChief Executive OfficerSep 15Sale427.139,0003,844,1706,100,868Sep 17 05:23 PM
Andres JuanSee remarksSep 15Sale427.135,0002,135,6500Sep 17 05:26 PM
Hoge StephenPresidentSep 13Option Exercise5.9520,000118,9001,629,597Sep 14 04:15 PM
Andres JuanSee remarksSep 13Option Exercise12.2115,000183,15015,000Sep 14 04:20 PM
Hoge StephenPresidentSep 13Sale447.4120,0008,948,2001,609,597Sep 14 04:15 PM
Andres JuanSee remarksSep 13Sale447.4115,0006,711,1500Sep 14 04:20 PM
Andres JuanSee remarksSep 10Option Exercise12.215,00061,0505,000Sep 14 04:20 PM
Andres JuanSee remarksSep 10Sale461.855,0002,309,2500Sep 14 04:20 PM
Bancel StephaneChief Executive OfficerSep 09Sale429.9910,0004,299,9007,244,880Sep 10 04:14 PM
Andres JuanSee remarksSep 08Option Exercise12.215,00061,0505,000Sep 09 04:23 PM
Bancel StephaneChief Executive OfficerSep 08Sale433.729,0003,903,4806,113,868Sep 10 04:14 PM
Andres JuanSee remarksSep 08Sale433.725,0002,168,6000Sep 09 04:23 PM
Andres JuanSee remarksSep 07Option Exercise12.215,00061,0505,000Sep 09 04:23 PM
Andres JuanSee remarksSep 07Sale409.595,0002,047,9500Sep 09 04:23 PM
Hoge StephenPresidentSep 03Option Exercise0.9910,0009,9001,619,597Sep 07 04:18 PM
Andres JuanSee remarksSep 03Option Exercise12.215,00061,0505,000Sep 07 04:24 PM
Hoge StephenPresidentSep 03Sale392.3510,0003,923,5001,609,597Sep 07 04:18 PM
Andres JuanSee remarksSep 03Sale392.355,0001,961,7500Sep 07 04:24 PM
Hoge StephenPresidentSep 02Option Exercise0.9910,0009,9001,619,597Sep 03 08:58 AM
Hoge StephenPresidentSep 02Sale393.1310,0003,931,3001,609,597Sep 03 08:58 AM
Bancel StephaneChief Executive OfficerSep 02Sale393.1310,0003,931,3007,254,880Sep 03 09:04 AM
Andres JuanSee remarksSep 01Option Exercise12.215,00061,0505,000Sep 03 08:56 AM
Andres JuanSee remarksSep 01Sale381.825,0001,909,1000Sep 03 08:56 AM
Bancel StephaneChief Executive OfficerSep 01Sale381.829,0003,436,3806,126,868Sep 03 09:04 AM
Andres JuanSee remarksAug 30Option Exercise12.2115,000183,15015,000Aug 31 04:49 PM
Andres JuanSee remarksAug 30Sale368.9315,0005,533,9500Aug 31 04:49 PM
Andres JuanSee remarksAug 27Option Exercise12.215,00061,0505,000Aug 31 04:49 PM
Andres JuanSee remarksAug 27Sale398.125,0001,990,6000Aug 31 04:49 PM
Bancel StephaneChief Executive OfficerAug 26Sale395.4510,0003,954,5007,264,880Aug 27 04:36 PM
Andres JuanSee remarksAug 25Option Exercise12.215,00061,0505,000Aug 27 04:40 PM
Bancel StephaneChief Executive OfficerAug 25Sale391.599,0003,524,3106,139,868Aug 27 04:36 PM
Andres JuanSee remarksAug 25Sale391.595,0001,957,9500Aug 27 04:40 PM
Hoge StephenPresidentAug 24Option Exercise10.905,00054,5001,614,597Aug 25 04:20 PM
Hoge StephenPresidentAug 24Sale403.985,0002,019,9001,609,597Aug 25 04:20 PM
Hoge StephenPresidentAug 23Option Exercise4.2915,00064,4001,624,597Aug 25 04:20 PM
Andres JuanSee remarksAug 23Option Exercise12.215,00061,0505,000Aug 24 04:29 PM
Hoge StephenPresidentAug 23Sale398.8515,0005,982,7631,609,597Aug 25 04:20 PM
Andres JuanSee remarksAug 23Sale390.115,0001,950,5500Aug 24 04:29 PM
Andres JuanSee remarksAug 20Option Exercise12.215,00061,0505,000Aug 24 04:29 PM
Andres JuanSee remarksAug 20Sale374.885,0001,874,4000Aug 24 04:29 PM
Bancel StephaneChief Executive OfficerAug 19Sale385.0010,0003,850,0007,274,880Aug 20 09:12 AM
Andres JuanSee remarksAug 18Option Exercise12.215,00061,0505,000Aug 20 09:17 AM
Bancel StephaneChief Executive OfficerAug 18Sale407.009,0003,663,0006,152,868Aug 20 09:12 AM
Andres JuanSee remarksAug 18Sale407.005,0002,035,0000Aug 20 09:17 AM
Andres JuanSee remarksAug 16Option Exercise12.2115,000183,15015,000Aug 18 04:48 PM
Andres JuanSee remarksAug 16Sale379.2715,0005,689,0500Aug 18 04:48 PM
Andres JuanSee remarksAug 13Option Exercise12.215,00061,0505,000Aug 16 04:58 PM